Patents by Inventor Stephan A. Sieber

Stephan A. Sieber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Beta-lactones as antibacterial agents
    Patent number: 9521845
    Abstract: The present invention relates to specific beta-lactone compounds and compositions thereof for the treatment of infections, such as, e.g., infections with bacteria or infections with protozoa, in particular infections with Gram-positive and/or Gram-negative bacteria and of infectious diseases caused by or related to Gram-positive and/or Gram-negative bacteria, and to the modulation of virulence of Gram-positive and/or Gram-negative bacteria or of protozoa by specific beta-lactone compounds. The invention further relates to the use of the compounds or compositions for preventing or eliminating biofilms.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: December 20, 2016
    Assignee: LUDWIG-MAXIMILIANS-UNIVERSITÄT-MÜNCHEN
    Inventors: Stephan A. Sieber, Thomas Bottcher
  • BETA-LACTONES AS ANTIBACTERIAL AGENTS
    Publication number: 20140163094
    Abstract: The present invention relates to specific beta-lactone compounds and compositions thereof for the treatment of infections, such as, e.g., infections with bacteria or infections with protozoa, in particular infections with Gram-positive and/or Gram-negative bacteria and of infectious diseases caused by or related to Gram-positive and/or Gram-negative bacteria, and to the modulation of virulence of Gram-positive and/or Gram-negative bacteria or of protozoa by specific beta-lactone compounds. The invention further relates to the use of the compounds or compositions for preventing or eliminating biofilms.
    Type: Application
    Filed: September 16, 2013
    Publication date: June 12, 2014
    Inventors: Stephan A. Sieber, Thomas Bottcher
  • Beta-lactones as antibacterial agents
    Patent number: 8669283
    Abstract: The present invention relates to specific beta-lactone compounds and compositions thereof for the treatment of infections, such as, e.g., infections with bacteria or infections with protozoa, in particular infections with Gram-positive and/or Gram-negative bacteria and of infectious diseases caused by or related to Gram-positive and/or Gram-negative bacteria, and to the modulation of virulence of Gram-positive and/or Gram-negative bacteria or of protozoa by specific beta-lactone compounds. The invention further relates to the use of the compounds or compositions for preventing or eliminating biofilms.
    Type: Grant
    Filed: February 4, 2009
    Date of Patent: March 11, 2014
    Assignee: Ludwig-Maximilians-Universitat Munchen
    Inventors: Stephan A. Sieber, Thomas Böttcher
  • Beta-lactones as antibacterial agents
    Patent number: 8563598
    Abstract: The present invention relates to specific beta-lactone compounds and compositions thereof for the treatment of infections, such as, e.g., infections with bacteria or infections with protozoa, in particular infections with Gram-positive and/or Gram-negative bacteria and of infectious diseases caused by or related to Gram-positive and/or Gram-negative bacteria, and to the modulation of virulence of Gram-positive and/or Gram-negative bacteria or of protozoa by specific beta-lactone compounds. The invention further relates to the use of the compounds or compositions for preventing or eliminating biofilms.
    Type: Grant
    Filed: February 4, 2009
    Date of Patent: October 22, 2013
    Assignee: Ludwig-Maximilians-Universitat Munchen
    Inventors: Stephan A. Sieber, Thomas Böttcher
  • BETA-LACTONES AS ANTIBACTERIAL AGENTS
    Publication number: 20110196027
    Abstract: The present invention relates to specific beta-lactone compounds and compositions thereof for the treatment of infections, such as, e.g., infections with bacteria or infections with protozoa, in particular infections with Gram-positive and/or Gram-negative bacteria and of infectious diseases caused by or related to Gram-positive and/or Gram-negative bacteria, and to the modulation of virulence of Gram-positive and/or Gram-negative bacteria or of protozoa by specific beta-lactone compounds. The invention further relates to the use of the compounds or compositions for preventing or eliminating biofilms.
    Type: Application
    Filed: February 4, 2009
    Publication date: August 11, 2011
    Inventors: Stephan A. Sieber, Thomas Böttcher